Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

If the company can put the funding on the balance sheet, the research for B-Absssi is a LOCK (99%+). There is even a decent chance for a SUPERIOR result versus the comparator. After that study is COMPLETE, B is worth about $750 million.

There are a lot more uncertainties surrounding B-OM. If there is a successful phase 2 with good efficacy, add another $ amount to the total. How much? Well, the SNGX result added ALMOST NOTHING to its market cap, but on the other hand it hasn't dropped 30%-70% like other micro biotechs. So figure SNGX phase 2 result was worth half their current market cap, which is about $30million. I conclude that a successful P2 for B-OM may not be worth a whole lot...unless the results are "blowout". Now a successful P3, on the other hand, would be worth a decent amount to prospective buyers of the platform.

So maybe when CTIX gets through with both ABSSSI and OM phase 3, we could be talking a billion. By that time there will likely be around 200 million shares fully loaded...so here's $5 again.